Role of BCL11B in CD4+ T Cells
Role of BCL11B in CD4+ T Cells
批准号:
7321194
负责人:
Dorina Avram
金额:
$39.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-16 至 2012-08-31
关键词:
AddressApoptosisAutoimmune DiseasesAutoimmunityBiochemicalCCND1 geneCD4 Positive T LymphocytesCD8B1 geneCell DeathCell physiologyCellsComplexCytokine ReceptorsDefectDevelopmentDiseaseDistalEffector CellGene ExpressionGerm LinesHypersensitivityIL2 geneImmune responseIn VitroInflammationInterleukin-2Knock-outKnockout MiceKnowledgeLymphoidMature T-LymphocyteMediationMusNuRD complexOrganOutcomePeripheralPhosphorylationPlayPopulationProcessProductionResearch PersonnelRoleSecondary toStagingT-Cell ActivationT-Cell DevelopmentT-LymphocyteTestingTh2 CellsThymus GlandTranscriptional RegulationTransgenic MiceTransgenic Organismscytokinein vivoleukemogenesismouse modelnovelprogramspromoterresearch studyresponsethymocytetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Many aspects of transcriptional control of T cell development, CD4+ T cell activation and effector function, as well as their relation to disease states, such as autoimmunity, inflammation and allergy remain to be uncovered. Our preliminary results demonstrate that the novel transcription factor BCL11B plays a critical role at the double positive (DP) stage of T cell development in positive selection, and also controls survival/apoptosis of DP thymocytes. Therefore in Aim 1 we propose to investigate the role of BCL11B in the development from double positive to single positive thymocytes, specifically in the process of positive selection. For these studies we will conditionally remove BCL11B starting with DP thymocytes and we will investigate positive selection both in vivo and in vitro, as well as the biochemical mechanisms by which BCL11B controls the process. In aim 2 we propose to investigate the role of BCL11B in the control of programmed cell death at the DP stage of T cell development and the mechanisms by which BCL11B controls this process. BCL11B is also present also in mature CD4+ T cells, including Th1 and Th2 effector cells, and regulates expression of interleukin-2 and several cytokines and cytokine receptors. Therefore in aim 3 we propose to study the role of BCL11B in the control of mature CD4+ T cell function. Through the studies under this aim, we will specifically assess the role of BCL11B in CD4 + T cell activation and in Th1/Th2 cell polarization. In addition, we will investigate the role of BCL11B in survival and proliferation of mature CD4+ T lymphocytes. Additionally, we will investigate the implication of the NuRD complex, as well as of components of the coactivator complex, in the mediation of BCL11B transcriptional control. Moreover, we will investigate the modulation of BCL11B transcriptional regulatory function by phosphorylation in response to T cell activation. Successful completion of these studies will elucidate the role of BCL11B after beta selection, as well as in mature CD4+ T lymphocytes. In addition, these studies will enhance our understanding of the transcriptional control of late stages of T cell development and mature CD4 T cell function, and have important implications for autoimmune diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
-
批准号:10667165
-
项目类别:
-
资助金额:$79.83万
-
财政年份:2023
-
负责人:Dorina Avram
-
依托单位:
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
-
批准号:10391539
-
项目类别:
-
资助金额:$78.72万
-
财政年份:2021
-
负责人:Dorina Avram
-
依托单位:
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
-
批准号:10597043
-
项目类别:
-
资助金额:$78.72万
-
财政年份:2021
-
负责人:Dorina Avram
-
依托单位:
Tolerogenic dual microparticle system for treatment of multiple sclerosis
-
批准号:9918870
-
项目类别:
-
资助金额:$52.1万
-
财政年份:2017
-
负责人:Dorina Avram
-
依托单位:
Transcriptional control in innate lymphoid type II cells
-
批准号:8732115
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2014
-
负责人:Dorina Avram
-
依托单位:
Transcriptional control in innate lymphoid type II cells
-
批准号:8853814
-
项目类别:
-
资助金额:$18.6万
-
财政年份:2014
-
负责人:Dorina Avram
-
依托单位:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
-
批准号:8021853
-
项目类别:
-
资助金额:$23.23万
-
财政年份:2008
-
负责人:Dorina Avram
-
依托单位:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
-
批准号:7760538
-
项目类别:
-
资助金额:$23.46万
-
财政年份:2008
-
负责人:Dorina Avram
-
依托单位:
BCL11B in Immune Regulation
-
批准号:8691305
-
项目类别:
-
资助金额:$20.51万
-
财政年份:2008
-
负责人:Dorina Avram
-
依托单位:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
-
批准号:7437569
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2008
-
负责人:Dorina Avram
-
依托单位:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
-
批准号:8213720
-
项目类别:
-
资助金额:$23.23万
-
财政年份:2008
-
负责人:Dorina Avram
-
依托单位:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
-
批准号:7563954
-
项目类别:
-
资助金额:$23.58万
-
财政年份:2008
-
负责人:Dorina Avram
-
依托单位:
Role of BCL11B in CD4+ T Cells
-
批准号:8602791
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2007
-
负责人:Dorina Avram
-
依托单位:
Role of BCL11B in CD4+ T Cells
-
批准号:7497510
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2007
-
负责人:Dorina Avram
-
依托单位:
Role of Bcl11b in CD4+ T cells and innate lymphoid cells
-
批准号:9975680
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2007
-
负责人:Dorina Avram
-
依托单位:
Role of Bcl11b in CD4+ T cells and innate lymphoid cells
-
批准号:10425371
-
项目类别:
-
资助金额:$46.52万
-
财政年份:2007
-
负责人:Dorina Avram
-
依托单位:
Role of BCL11B in CD4+ T Cells
-
批准号:9001888
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2007
-
负责人:Dorina Avram
-
依托单位:
Role of BCL11B in CD4+ T Cells
-
批准号:8295825
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2007
-
负责人:Dorina Avram
-
依托单位:
Role of BCL11B in CD4+ T Cells
-
批准号:8122150
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2007
-
负责人:Dorina Avram
-
依托单位:
Role of BCL11B in CD4+ T Cells
-
批准号:7910726
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2007
-
负责人:Dorina Avram
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: